Home Your basket
• Otomycosis: Clinical and ...
   Price 5.50 €
• Liposarcoma of the hypoph...
   Price 5.50 €
• Schwannoma of the postcri...
   Price 5.50 €
• Congenital cholesteatoma ...
   Price 5.50 €
• A non-linear model of lar...
   Price 10.50 €
• Understanding the use of ...
   Price 10.50 €
• Role of [18]-FDG PET/CT i...
   Price 10.50 €
• Traditional and emerging ...
   Price 10.50 €
• Relation between actinomy...
   Price 10.50 €
• Post operative Caldwell-L...
   Price 10.00 €
• Validity of cervical ausc...
   Price 12.00 €
• Solitary myofibroma of th...
   Price 5.50 €
• Cholesteatoma behind a no...
   Price 10.50 €
• Airbag and hearing loss: ...
   Price 8.50 €
• Diagnosis of non organic ...
   Price 8.50 €
• Extramuscular soft tissue...
   Price 8.50 €
• Enlarged marginal incisio...
   Price 10.50 €
• Peptide receptor radionuc...
   Price 14.00 €
• Fistulisation of a tuberc...
   Price 5.50 €
• Abscess tonsillectomy for...
   Price 10.50 €
• Adenocarcinoma of the eth...
   Price 8.50 €
• Static management of lago...
   Price 10.50 €
• Navigation in head and ne...
   Price 10.50 €
• Usefulness and limitation...
   Price 10.50 €
• Otogenic pneumocephalus: ...
   Price 5.50 €
• Evaluation of the use of ...
   Price 8.50 €
• Principes underlying the ...
   Price 10.50 €
• Perilymphatic Gusher as a...
   Price 10.50 €
• Functional anatomy of the...
   Price 14.00 €
• Pulsatile tinnitus and ve...
   Price 8.50 €
• The role of larynx kinest...
   Price 10.50 €
• Importance of swallowing ...
   Price 10.50 €
• Assumptions in surgical t...
   Price 8.50 €

Total Order 305.50 €

contents
2019
   N# 1 |
2018
   N# 1 | 2 | 3 | 4 | 5 |
2017
   N# 1 | 2 | 3 | 4 | 5 |
2016
   N# 1 | 2 | 3 | 4 | 5 |
2015
   N# 1 | 2 | 3 | 4 | 5 |
2014
   N# 1 | 2 | 3 | 4 | 5 |
2013
   N# 1 | 2 | 3 | 4 | 5 |
2012
   N# 1 | 2 | 3 | 4 | 5 |
2011
   N# 1 | 2 | 3 | 4 | 5 |
2010
   N# 1 | 2 | 3 | 4 | 5 |
2009
   N# 1 | 2 | 3 | 4 | 5 |
2008
   N# 1 | 2 | 3 | 4 | 5 |
2007
   N# 1 | 2 | 3 | 4 | 5 |
2006
   N# 1 | 2 | 3 | 4 | 5 |
2005
   N# | 1 | 2 | 3 | 4 | 5 |
2004
   N# 1 | 2 | 3 | 4 | 5 |
2003
   N# 1 | 2 | 3 | 4 | 5 |
2002
   N# 1 | 2 | 3 | 4 | 5 |
2001
   N# 1 | 2 | 3 | 4 | 5 |
2000
   N# | 1 | 2 | 3 | 4 | 5 |
1999
   N# 1 | 2 | 3 | 4 | 5 |
1998
   N# 1 | 2 | 3 | 5 |
1997
   N# 1 | 2 | 3 | 4 | 5 |
1996
   N# 4 | 5 |

Click on the number of the review to see the content
Teaching bulletin CME
List of all teaching bulletins CME.
Editor reading committee
Editor reading committee.
To publish...
Instructions for authors
Archives Press and Books
Select of books and press articles.
Mailing list
News information letter.
Subscription prices


If you wish to adjust the size of the displayed characters, click in the high menu on "Your account" and choose the desired size.



  Contents > Previous page > Article detail print Order
o Issue N# 4 - 2001 o

HEAD AND NECK SURGERY

Utility of positron emission tomography for follow-up after therapy of head and neck squamous cell carcinomas


Authors : Cl. Conessa, Ph. Clement, H. Foehrenbach, Ph. Maszelin, P. Verdalle, M. Kossowski, J.-L. Poncet (Paris)

Ref. : Rev Laryngol Otol Rhinol. 2001;122,4:253-258.

Article published in french
Downloadable PDF document french



Summary : This study aimed at pointing out the supply of the positron emission tomography (PET) in the posttherapeutic follow-up of the head and neck squamous cell carcinomas and to determine the best period to perform this test. Patients and methods: twenty patients have been included in this series, 16 men and 4 women. The PET was performed between 3 and 6 months after the end of all therapy. It systematically included radiation therapy. The results of the PET have been compared with those obtained by histology. The average distance of the follow-up of the patients after the achievement of the test was 11 months. Results: they divided up according to the presence or not of an abnormal fixation on the PET imaging. Negative PETs: eigth cases. Among those, a patient showed a metastatic cervical adenopathy at five months. Positive PETs: twelve cases which can be divided into three groups according to the area of the fixation. Primary site: 8 cases, 4 of which false-positive. Cervical lymph nodes: one case. Other sites: three cases. In our series PET had a sensitivity of 87% and a specificity of 67%. Conclusion: the PET is an original imaging as it allows a corporal metabolic study at one go. It seems to be very useful in the follow-up of patients who show a head and neck squamous cell carcinoma.The best period to perform it is the third or fourth posttherapeutic month. The high sensitivity is interesting within the context of an early detection of a residual tumour, for it allows to think of a suitable therapy quicker.

Price : 8.50 €      order
|


Subscribe online - Pay by credit card!


© Copyright 1999-2024 - Revue de Laryngologie   Réalisation - Hébergement ELIDEE